Melatonin prolonged-release (Slenyto) for insomnia in neurodevelopmental disorders |
New Drug Evaluations |
March 2019 |
Ertugliflozin for type 2 diabetes |
New Drug Evaluations |
January 2019 |
Cariprazine for the treatment of schizophrenia in adults |
New Drug Evaluations |
December 2018 |
5-aminolevulinic acid patches for actinic keratosis |
New Drug Evaluations |
November 2018 |
Semaglutide for type 2 diabetes |
New Drug Evaluations |
September 2018 |
Fluticasone, umeclidinium, and vilanterol (Trelegy Ellipta) for COPD |
New Drug Evaluations |
May 2018 |